Anavex Life Sciences Corp (AVXL)

[Investor2014]

And although the Anavex data is only on 6 patients without placebo at this point, the biomarkers are completely and strongly aligned with the RSQB results which can’t be influenced by placebo effect on patients or their caregivers.

So far looking good with the potential of beating the socks of of any Rett drug so far.

Btw. is ACADIA ever going to start that P3 trial or will rettsyndrome.org have to keep on adding to the series of lame and embarrassing update letters.